Why Did Otsuka Become A Leader In Virtual Trial Adoption?

Source: Clinical Leader

In May 2020 Clinical Leader Live was proud to feature Brian Johnson, Director of Applied Innovation at Otsuka, and Katherine Vandebelt, Global Head of Clinical Innovation for Oracle to discuss whether pharma companies were ready to embrace virtual trials. During the presentation, Johnson and Vandebelt covered several topics, including how COVID-19 has changed the view of virtual trials, whether they will become a future best practice, how Otsuka opted to be a leader in the adoption of virtual technologies, the challenges and benefits of implementing virtual trials, incorporating virtual components into trial protocols, the impact these technologies can have on recruitment and retention, and therapeutic areas where virtual trials might have the biggest impact.

In this video, Johnson discusses why Otsuka chose to become an early adopter of virtual trial technologies.

Or click here to see the complete interview.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader